Microglial Dysregulation in Psychiatric Disease
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Microglia, the brain's resident immune cells, are phagocytes of the macrophage lineage that have a key role in responding to inflammation and immune challenge in the brain. More recently, they have been shown to have a number of important roles beyond immune surveillance and response, including synaptic pruning during development and the support of adult neurogenesis. Microglial abnormalities have been found in several neuropsychiatric conditions, though in most cases it remains unclear whether these are causative or are a reaction to some other underlying pathophysiology. Here we summarize postmortem, animal, neuroimaging, and other evidence for microglial pathology in major depression, schizophrenia, autism, obsessive-compulsive disorder, and Tourette syndrome. We identify gaps in the existing literature and important areas for future research. If microglial pathology proves to be an important causative factor in these or other neuropsychiatric diseases, modulators of microglial function may represent a novel therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, microglia may play roles in neurodevelopmental and psychiatric diseases such as autism, schizophrenia (Scz) and depression (16, 17).”
From An environment-dependent transcriptional network specifies human microglia identity (2017) · cites this paper as [17]
In the citing paper
“the review also found that aggregated animal studies commonly implicated microglial activation with depressive phenotypes in rats that undergo chronic psychological stress, neonatal LPS injection, and mice with CX3CR1 (fractalkine receptor) deficiencies.”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Frick et al., 2013
In the citing paper
“A review (Frick et al., 2013) detailing studies concerning cytokine effects on different immune cells indicated that data on microglial dysregulation are “limited” and reported mixed results relating to increased microglial densities and activation in diagnosed MDD patients in both clinical and post-mortem examinations.”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Frick et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 2×
“Microglia have been found to be required for the development of mature synapses during embryogenesis [1] and to regulate the number of functional synapses both in culture [2] and in vivo [3].”
BackgroundMicroglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 3×
“However, dysregulation of this physiological process can lead to neurodegeneration [8, 13].”
BackgroundNeuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“An initial study found marked microglial activation, measured by immunohistochemical quantification of HLA-DR expression, in the cerebellum, several cortical regions, and white matter in patients with autism [85].”
BackgroundStress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Self-citationSynaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 2×
“[5] R.”
BackgroundMicroglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622 · cited 1×
“They also regulate adult neurogenesis [4].”
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
The Role of Microglia in the Healthy Brain: Figure 1.
Tremblay, M.-È., Stevens, B., Sierra, A., Wake, H., Bessis, A., & Nimmerjahn, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4158-11.2011 · Cited by 992 · cited 2×
“Microglia are highly motile cells, extruding and retracting their processes every few minutes [9].”
Background
Cited by
Items 101–200 of 335
Trojan, E., Ślusarczyk, J., Chamera, K., Kotarska, K., Głombik, K., Kubera, M., & Basta-Kaim, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00779 · Cited by 52
“…are required for maintaining microglia in a “resting state” through modulation of their activity and pro-inflammatory factor release (Cardona Frontiers in Pharmacology | www.frontiersin.org 12 November 2017 | Volume 8 | Article 779 et al., 2006; Corona et al., 2010; Frick et al., 2013).”
BackgroundPredictors of current functioning and functional decline in schizophrenia
Joseph, J., Kremen, W. S., Franz, C. E., Glatt, S. J., van de Leemput, J., Chandler, S. D., Tsuang, M. T., & Twamley, E. W. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.038 · Cited by 52
“The study of biological pathways that link depression and schizophrenia spectrum disorders (Frick et al., 2013; Jun et al., 2012; Ray et al., 2014; Walton et al., 2014; Yu et al., 2013) could also be important for improving our”
Vagus nerve stimulation and Neurotrophins: a biological psychiatric perspective
Rosso, P., Iannitelli, A., Pacitti, F., Quartini, A., Fico, E., Fiore, M., Greco, A., Ralli, M., & Tirassa, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.034 · Cited by 51
Assi, E., Cazzato, D., De Palma, C., Perrotta, C., Clementi, E., & Cervia, D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/309302 · Cited by 50
Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
Jiang, L., Wu, X., Wang, S., Chen, S., Zhou, H., Wilson, B. C., Jin, C., Lu, R., Xie, K., Wang, Q., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0573-z · Cited by 50
“Indeed, a wide variety of psychoactive drugs, such as antidepressants and antipsychotics, have been shown to suppress microglial activation [23, 47, 64, 65].”
BackgroundStone, T. W., & Williams, R. O. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16015 · Cited by 49
“…generation of hepatic kynurenine will add to existing plasma levels of this compound resulting in a secondary increase in the CNS, a change which would alter the quinolinic acid: kynurenic acid ratio and affect neuronal excitability and glial function (Frick et al., 2013 ; Sanacora et al., 2012 ).”
P2X7R antagonists in chronic stress-based depression models: a review
von Mücke-Heim, I.-A., Ries, C., Urbina-Treviño, L., & Deussing, J. M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01306-3 · Cited by 49
P2X2 receptors in pyramidal neurons are critical for regulating vulnerability to chronic stress
Kuang, X., Zhang, C.-Y., Yan, B.-Y., Cai, W.-Z., Lu, C., Xie, L.-J., Li, S.-J., Kong, P., Fan, J., Pan, S.-M., et al. (2022) · Theranostics · doi:10.7150/thno.72144 · Cited by 47
“And P2X7R, expressed on microglia and macrophage, play a role in mediating stress and depression [20-23].”
BackgroundThe therapeutic potential of bone marrow‐derived macrophages in neurological diseases
Zhou, K., Han, J., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13964 · Cited by 47
The Development of Early Life Microbiota in Human Health and Disease
Lv, H., Zhang, L., Han, Y., Wu, L. M., & Wang, B. (2021) · Engineering · doi:10.1016/j.eng.2020.12.014 · Cited by 47
Depressive disorders: Processes leading to neurogeneration and potential novel treatments
Brown, G. M., McIntyre, R. S., Rosenblat, J. D., & Hardeland, R. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.023 · Cited by 46
“However, the chronic inflammatory state associated with MDD and BD leads to chronic microglia over activation resulting in neurodegeneration by aberrantly destroying important neural pathways(Frick et al., 2013; Stertz et al., 2013).”
BackgroundProfile of minocycline and its potential in the treatment of schizophrenia
Zhang, L., & Zhao, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s64236 · Cited by 45
“the processes involving modulators of microglial activation may represent a novel therapeutic strategy.(50,51)”
Roshan‐Milani, S., Seyyedabadi, B., Saboory, E., Parsamanesh, N., & Mehranfard, N. (2021) · Stress · doi:10.1080/10253890.2021.1942828 · Cited by 45
“Indeed, previous reports have indicated increased microglial activity prevalent among patients with anxiety (Frick et al., 2013) and in animals with anxiety-like symptoms (Wohleb et al., 2011, 2012).”
BackgroundŚlusarczyk, J., Trojan, E., Wydra, K., Głombik, K., Chamera, K., Kucharczyk, M. W., Budziszewska, B., Kubera, M., Lasoń, W., Filip, M., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.008 · Cited by 44
Novel Methods for Microglia Segmentation, Feature Extraction, and Classification
Ding, Y., Pardon, M., Agostini, A., Faas, H., Duan, J., Ward, W. O. C., Easton, F., Auer, D. P., & Bai, L. (2016) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2016.2591520 · Cited by 43
“They are also essential to learning andmemory [4], [5], protect neurons from damage, and mediate pain [6], [7].”
BackgroundSexual Differentiation and Sex Differences in Neural Development
Turano, A., Osborne, B. F., & Schwarz, J. M. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_56 · Cited by 43
Rodríguez‐Arias, M., Montagud‐Romero, S., Carrión, A. M. G., Perez, C. F., Pérez‐Villalba, A., Marco, E. M., López‐Gallardo, M., Viveros, M., & Miñarro, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206421 · Cited by 43
Morris, G., Puri, B. K., Maes, M. H. J., OLIVE, L. S., Berk, M., & Carvalho, A. F. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109858 · Cited by 43
Coelho‐Santos, V., Cardoso, F. L., Leitão, R. A., Ribeiro, C., & Silva, A. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.016 · Cited by 42
“Microglia are the main innate immune cells and their dysregulation is associated with psychiatric disorders (Frick et al., 2013).”
Sex Steroids, Adult Neurogenesis, and Inflammation in CNS Homeostasis, Degeneration, and Repair
Larson, T. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00205 · Cited by 43
Zhang, J., Yi, S., Li, Y., Xiao, C., Liu, C., Jiang, W., Yang, C., & Zhou, T. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05553-5 · Cited by 41
Brain Biomarkers of Vulnerability and Progression to Psychosis
Cannon, T. D. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv173 · Cited by 41
Mario, A., Leccisotti, I., Mollica, A., Silvio, M., Claudia, A., Mariaclaudia, M., & Bellomo, A. (2024) · PubMed Central · doi:10.36131/cnfioritieditore20240103 · Cited by 40
“Microglia, under physiological conditions, play an important role in neuroplasticity, facilitating pruning in many brain regions (Frick et al., 2013).”
BackgroundRole of neuroglia in neuropathic pain and depression
Liu, Q., Li, R., Yang, W., Cui, R., & Li, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105957 · Cited by 39
Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities
Rahman, S., & Alzarea, S. I. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.010 · Cited by 38
Deficient Autophagy in Microglia Aggravates Repeated Social Defeat Stress-Induced Social Avoidance
Sakai, M., Yu, Z., Hirayama, R., Nakasato, M., Kikuchi, Y., Ono, C., Komatsu, H., Nakanishi, M., Yoshii, H., Stellwagen, D., et al. (2022) · Neural Plasticity · doi:10.1155/2022/7503553 · Cited by 38
“Their activation has been involved in various psychiatric disorders, including MDD [16].”
BackgroundPallier, P. N., Ferrara, M., Romagnolo, F., Ferretti, M. T., Soreq, H., & Cerase, A. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102353 · Cited by 37
Su, W., Ju, J., Gu, M., Wang, X., Liu, S., Yu, J., & Mu, D.-L. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02786-x · Cited by 37
“There is mounting evidence that microglia play an etiological role in this process [31, 32].”
Diagnostic Issues in Early-Onset Obsessive-Compulsive Disorder and their Treatment Implications
Burchi, E., & Pallanti, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180426151746 · Cited by 37
Zhang, J., Chang, L., Pu, Y., & Hashimoto, K. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.128 · Cited by 36
Valentine, C., Steffert, T., Mitcheltree, H., & Steemers, K. (2024) · Buildings · doi:10.3390/buildings14051292 · Cited by 36
Microglia in ALS: Insights into Mechanisms and Therapeutic Potential
Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025) · Cells · doi:10.3390/cells14060421 · Cited by 35
“…[19,21]. they may release persistently high levels of ROSs and NO or fail to clear out debris pathogens, further promoting Furthermore, and neuronal damage and disease progression [19,21]. aggregates, releasing neurotrophic and anti-in fl ammatory factors, and providing immune surveillance.”
The Role of Cathepsins in Memory Functions and the Pathophysiology of Psychiatric Disorders
Niemeyer, C., Matosin, N., Kaul, D., Philipsen, A., & Gassen, N. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00718 · Cited by 35
“Changes in microglia markers have been reported in a number of psychiatric conditions including anxiety (59), depression (60, 61), and schizophrenia (62).”
BackgroundAhmed, A., Misrani, A., Tabassum, S., Yang, L., & Long, C. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.028 · Cited by 35
Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment
Gong, Y., Chen, A., Zhang, G., Shen, Q., Zou, L., Li, J., Miao, Y., & Liu, W. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85259 · Cited by 35
“Microglial dysregulation often in a series of psychiatric disorders [148].”
BackgroundCorrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 34
Psychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia’s Gut Feeling
Fakhfouri, G., Mijailović, N. R., & Rahimian, R. (2024) · Cells · doi:10.3390/cells13020177 · Cited by 33
“Multiple lines of evidence now substantiate the concept that microglia have a significant role in processes like neurogenesis and synaptic pruning, even in the absence of any inflammatory or immune-related stimuli [104].”
BackgroundChauhan, A., Zangbede, F. O. Q., Abbas, A., Bradley, D. S., Nechaev, S., Singh, B. B., Sharma, J., & Mishra, B. B. (2015) · ASN NEURO · doi:10.1177/1759091415592126 · Cited by 33
“In normal physiological conditions, microglia exhibit resting/quiescent phenotypes with low basal level expression of CD11b, while an increased CD11b expression is among the earliest signs of microglial response (Frick et al., 2013).”
BackgroundKim, H., Baek, S.-H., Kim, J., Ryu, S., Lee, J., Kim, J., Chung, Y., & Kim, S. (2023) · Schizophrenia · doi:10.1038/s41537-023-00398-1 · Cited by 31
“Stress-induced microglial activity releases in fl am-matory cytokines in individuals with a genetic predisposition, causing abnormal neurogenesis, neuronal degradation, and white matter abnormalities, all of which contribute to the pathophysiology of schizophrenia 3,4,9,10 .”
BackgroundOsborne, B. F., Turano, A., Caulfield, J. I., & Schwarz, J. M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.044 · Cited by 31
Xu, J., Frankovich, J., Liu, R.-J., Thienemann, M., Silverman, M. A., Farhadian, B., Willett, T. A., Manko, C., Columbo, L. A., Leibold, C. M., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.044 · Cited by 31
Self-citationNeuroadaptations and TGF-β signaling: emerging role in models of neuropsychiatric disorders
Mitra, S., Werner, C. T., & Dietz, D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01186-y · Cited by 30
Brain in flames – animal models of psychosis: utility and limitations
Wolf, S. A., Mattei, D., & Schweibold, R. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65564 · Cited by 31
“Recently, microglia have been identified as potential pathological key player in schizophrenia.(13) Evaluat-”
Kitagawa, Y., Nakaso, K., Horikoshi, Y., Morimoto, M., Omotani, T., Otsuki, A., Inagaki, Y., Sato, H., & Matsura, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-44006-8 · Cited by 29
Parente, A., Feltes, P. K., García, D. V., Sijbesma, J. W. A., Jeckel, C. M. M., Dierckx, R., de Vries, E. F. J., & Doorduin, J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.165019 · Cited by 29
“165019 Microglia are the resident macrophages of the central nervous system (1).”
BackgroundInflammation as a Mechanism of Bipolar Disorder Neuroprogression
Barichello, T., Giridharan, V. V., Bhatti, G. S., Sayana, P., Doifode, T., Macêdo, D. S., & Quevedo, J. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_173 · Cited by 28
Individualized Immunological Data for Precise Classification of OCD Patients
Lamothe, H., Baleyte, J., Smith, P., Pélissolo, A., & Mallet, L. (2018) · Brain Sciences · doi:10.3390/brainsci8080149 · Cited by 28
“Cytokines AND (OCD OR “Obsessive Compulsive Disorder”) Authors, Date Subjects Main Results Significance Konuk N. et al. (2007) [27] 31 OCD patients 31 controls -> OCD patients TNF-α > control TNF-α p < 0.001 -> OCD patients IL-6 > control IL-6 p < 0.001 Denys D. et al. (2004) [28] 50 OCD patients 25 controls -> OCD pa…”
BackgroundResultInfluentialTricyclic Antidepressants Modulate Stressed Mitochondria in Glioblastoma Multiforme Cells
Bielecka, A., Ludyga, T., Machnik, G., Gołyszny, M. J., & Obuchowicz, E. (2018) · Cancer Control · doi:10.1177/1073274818798594 · Cited by 28
“Due to strong activation of NF-kB factor in various tumors, and the fact that it is related to cancer development/invasion/ progression and inflammatory processes, suppression of NF-kB activity could be an anticancer therapeutic strategy or an important element of adjuvant treatment.(31,32) Among the drugs studied, on…”
BackgroundFeiger, J. A., Snyder, R. L., Walsh, M. J., Cissne, M. N., Cwiek, A. P., Al-Momani, S. I., & Chiou, K. S. (2022) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000754 · Cited by 27
Amorim, D., Puga, S., Bragança, R., Braga, A., Pertovaara, A., Almeida, A., & Pinto‐Ribeiro, F. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.003 · Cited by 27
“Furthermore, recent studies yielded ompelling evidence that releasing of proinflammatory mediators fter microglial activation also play a critical role in the developent of a depressive condition [22,23].”
ResultLiu, W., & Rask‐Andersen, H. (2018) · Journal of Otology · doi:10.1016/j.joto.2018.11.010 · Cited by 27
“CD11b, IBA1, and MHCII are frequently used as markers for macrophages and microglia (Frick et al., 2013).”
BackgroundZhang, Z.-X., Li, E., Yan, J.-P., Fu, W., Shen, P., Tian, S., & You, Y. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101959 · Cited by 27
Bhandari, R., Paliwal, J. K., & Kuhad, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_23 · Cited by 27
Autoantibodies and the Immune Hypothesis in Psychotic Brain Diseases: Challenges and Perspectives
Pathmanandavel, K., Starling, J., Dale, R. C., & Brilot, F. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/257184 · Cited by 27
“Both increased numbers and abnormal localisation of microglia in the CNS have also been reported [29, 53], findings that are consistent with the hypothesis that aberrant microglial activation plays a pathogenic role in schizophrenia (reviewed in [54]).”
Prostaglandins, pain, and inflammation.
Ferreira, S. H. (1986) · PubMed · Cited by 28
Serafini, G., Amore, M., & Rihmer, Z. (2015) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.157955 · Cited by 26
“inflammatory-mediated alterations underlying MDD and suicidal behavior.[11,12] Historically, glial cells”
BackgroundPiras, C., Pintus, R., Pruna, D., Dessì, A., Atzori, L., & Fanos, V. (2019) · Current Pediatric Reviews · doi:10.2174/1573396315666191022102925 · Cited by 26
Zhang, Z., Kang, W., Mi, Y., Zhong, X., & He, Y. (2025) · Pathogens · doi:10.3390/pathogens14111145 · Cited by 27
Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders
Slifstein, M., & Abi‐Dargham, A. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.002 · Cited by 25
Cortical Volume Differences in Subjects at Risk for Psychosis Are Driven by Surface Area
Buechler, R., Wotruba, D., Michels, L., Theodoridou, A., Metzler, S., Walitza, S., Hänggi, J., Kollias, S., Rössler, W., & Heekeren, K. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa066 · Cited by 25
Najjar, S., Pearlman, D. M., Hirsch, S., Friedman, K., Strange, J., Reidy, J., Khoukaz, M., Ferrell, R. B., Devinsky, O., Najjar, A., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.041 · Cited by 24
Anderson, W. D., Greenhalgh, A. D., Takwale, A., David, S., & Vadigepalli, R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00233 · Cited by 24
“As microglial functions are now implicated in the onset of Alzheimer’s disease, schizophrenia, epilepsy and intellectual disability (Frick et al., 2013; Abiega et al., 2016; Hong et al., 2016), appropriate assessment of subtle changes in microglial morphology may illuminate their homeostatic and…”
BackgroundVallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01086-1 · Cited by 24
“The dysregulated activation of microglia leads to the infiltration of brain by macrophages under pathological conditions [56].”
BackgroundCytokine profile in drug-naïve panic disorder patients
Quagliato, L. A., & Nardi, A. E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01835-y · Cited by 24
“Evidence points toward chronic activation of microglia in several mental health disorders, such as schizophrenia, bipolar disorder, depression, and autism [18, 19].”
BackgroundWhat does immunology have to do with brain development and neuropsychiatric disorders?
Leckman, J. F., de Alvarenga, P. G., Salto, A. B. R., & Johnson, I. N. S. (2019) · Revista de Medicina · doi:10.11606/issn.1679-9836.v98i4p241-253 · Cited by 23
Pharmacologic implications of inflammatory comorbidity in bipolar disorder
Rosenblat, J. D., Gregory, J. M., & McIntyre, R. S. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.06.007 · Cited by 24
Early Life Stress and the Fate of Kynurenine Pathway Metabolites
Coplan, J. D., George, R., Syed, S. A., Rozenboym, A. V., Tang, J. E., Fulton, S. L., & Perera, T. D. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.636144 · Cited by 23
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis
Gentile, A., Vito, F. D., Fresegna, D., Musella, A., Buttari, F., Bullitta, S., Mandolesi, G., & Centonze, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00243 · Cited by 23
“…in Cellular Neuroscience | www.frontiersin.org 1 June 2015 | Volume 9 | Article 243 conditions in both humans and animal models (Price and Drevets, 2010; Frick et al., 2013), raising the possibility that microglia may have a crucial role in mediating mood disorders in MS.”
Single Cell Transcriptome of Stress Vulnerability Network in mouse Prefrontal Cortex
Hing, B. W. Q., Mitchell, S. B., Filali, Y., Eberle, M., Hultman, I., Matkovich, M., Kasturirangan, M., Johnson, M., Wyche, W., Jimenez, A., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.05.023 · Cited by 22
Farhangian, M., Azarafrouz, F., Chavoshinezhad, S., & Dargahi, L. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136968 · Cited by 22
Yamasaki, K., Hasegawa, T., & Takeda, M. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12100 · Cited by 22
Ayilara, G. O., & Owoyele, B. V. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.05.010 · Cited by 21
Sun, Q., Ho, C., Zhang, X., Liu, Y., Zhang, R., & Wu, Z. (2022) · Food & Function · doi:10.1039/d1fo02716f · Cited by 20
Early Life Stress, Neuroinflammation, and Psychiatric Illness of Adulthood
Shin, S. H., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_6 · Cited by 20
Neuroinflammation and excitatory symptoms in bipolar disorder
Sani, G., Panaccione, I., & Spalletta, G. (2015) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.167304 · Cited by 20
Glial Markers of Suicidal Behavior in the Human Brain—A Systematic Review of Postmortem Studies
Yamamoto, M., Sakai, M., Yu, Z., Nakanishi, M., & Yoshii, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115750 · Cited by 20
“Several studies have reported an association between glial cells and suicidal behaviors based on post-mortem brain gene expression [8], morphological changes [9], cytokines [10], and neurotrophic factors [11].”
BackgroundAlmarghalani, D. A., Sha, X., Mrak, R. E., & Shah, Z. A. (2023) · Cells · doi:10.3390/cells12081153 · Cited by 19
“Activated microglia and persistent neuroinflammation contribute to cognitive impairment in such conditions as Parkinson’s disease [14], aging, Alzheimer’s disease [15], ischemic stroke [16,17], hemorrhagic stroke [18], and some psychiatric disorders [19].”
BackgroundBlood Vessels and Perivascular Phagocytes of Prefrontal White and Gray Matter in Suicide
Schnieder, T. P., Qin, I. D. Z., Trencevsja-Ivanovska, I., Rosoklija, G. B., Stankov, A., Pavlovski, G., Mann, J. J., & Dwork, A. J. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly103 · Cited by 18
Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01329-3 · Cited by 18
Boero, G., Tyler, R. E., O’Buckley, T. K., Balan, I. S., Besheer, J., & Morrow, A. L. (2022) · Biomolecules · doi:10.3390/biom12081134 · Cited by 18
“Acute stress activates microglia and increases pro-inflammatory cytokine production [60], as observed in neuropsychiatric disorders such as depression [61], anxiety [62], schizophrenia [63], and autism spectrum disorders [64].”
BackgroundSinger, W., Manthey, M., Panford-Walsh, R., Matt, L., Geisler, H.-S., Passeri, E., Baj, G., Tongiorgi, E., Leal, G., Duarte, C. B., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00325 · Cited by 19
Metabolic syndrome accentuates post-traumatic stress disorder-like symptoms and glial activation
Ribeiro, A. C. A. F., Batista, T. H., Rojas, V. C. T., Giusti‐Paiva, A., & Vilela, F. C. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112557 · Cited by 18
Functional Evaluations of Genes Disrupted in Patients with Tourette’s Disorder
Sun, N., Tischfield, J. A., King, R. A., & Heiman, G. A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00011 · Cited by 17
“Additionally, a dysregulated brain-immune system involving microglia cells was suggested to contribute to TD (32).”
BackgroundVasileva, L. V., Ivanovska, M. V., Murdjeva, M. A., Saracheva, K. E., & Georgiev, M. I. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.03.004 · Cited by 16
“This leads to an inflammatory glial response represented as production of pro-inflammatory cytokines and expression of several cell surface antigens (Frick et al., 2013; Walker et al., 2014; Wohleb et al., 2013).”
BackgroundTrichostatin A relieves anxiety-and depression-like symptoms in APP/PS1 mice
Su, Q., Ren, Y.-H., Liu, G.-W., Gao, Y., Zhang, J. Y., Zhang, J.-N., Pei, X.-X., & Li, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1333235 · Cited by 16
Therapeutic potential of NOX inhibitors in neuropsychiatric disorders
Kaur, P., Khan, H., Grewal, A. K., Dua, K., & Singh, T. G. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06424-5 · Cited by 18
“The abovementioned studies demonstrated that NOX inhibitors may show a neuroprotective action in schizophrenia disorder (Frick et al. 2013).”
BackgroundLi, Z., Cao, X., Ma, H., Cui, Y., Li, X., Wang, N., & Zhou, Y. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly051 · Cited by 16
Çetin, İ., Tezdig, I., Tarakçıoğlu, M. C., Kadak, M. T., Demirel, Ö. F., & Özer, Ö. F. (2016) · Biomarkers · doi:10.3109/1354750x.2016.1171901 · Cited by 15
“The encirclement of neurons bymicroglial processes suggest an important role of this cell–cell interaction in thepathophysiology of autism (Frick et al., 2013).”
BackgroundSulforaphane triggers a functional elongation of microglial process via the Akt signal
Wu, Y. H., Gao, M., Wu, J., Hu, P., Xu, X., Zhang, Y.-R., Wang, D., Chen, Z., & Huang, C. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.019 · Cited by 15
SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility
Lin, H., Liu, Y.-S., Huang, C., Cathomas, F., Liu, K., Wang, J., Cheng, H., Lai, S., Liu, Y., Chen, C., et al. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104800 · Cited by 14
Torii, K., Takagi, S., YOSHIMURA, R., & Miyata, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577832 · Cited by 14
Kosten, L., Verhaeghe, J. A. J., Verkerk, R. M., Thomae, D., Picker, L. D., Wyffels, L., Eetveldt, A. V., Dedeurwaerdere, S., Stroobants, S. G., & Staelens, S. G. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.01.013 · Cited by 14
Microglia-Induced Maladaptive Plasticity Can Be Modulated by NeuropeptidesIn Vivo
Morara, S., Colangelo, A. M., & Provini, L. (2015) · Neural Plasticity · doi:10.1155/2015/135342 · Cited by 14
“This effect should not be unexpected, as the involvement of microglia in psychiatric, psychological, and cognitive diseases is more and more recognized [37, 38].”
BackgroundChen, X., Huang, N., Namaka, M., & Xiao, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00451 · Cited by 14
“In addition, post-mortem and imaging studies have also suggested a critical role for microglial activation in the underlying pathogenesis of SZ patients (Frick et al., 2013).”
BackgroundGao, J., Zhang, H., Zhou, L., Liu, J., Zhuo, E., Shen, Y., Liu, X., & Shen, Q. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03792-z · Cited by 13
“In addition to the release of pro-inflammatory factors, the activation of microglia plays a key role in neuroinflammation [22].”
Zhou, L., Wu, Z., Li, Y., Xie, Y., Sun, L., Lin, S., Xiao, L., Wang, H., & Wang, G. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03082-1 · Cited by 13
“Clinical studies in patients with depression and anxiety support this view [26, 27].”
Role and characteristics of hippocampal region microglial activation in poststroke depression
Wei, L., Guo, J., Yu, X., Chen, H., Du, Y., Ji, Z., Xie, Y., & Qiu, Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.022 · Cited by 13
Preexposure to heat stress attenuates sepsis-associated inflammation and cognitive decline in rats
Jiang, S., Bai, L., Zhang, X., Zhou, X., & Liu, Y. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136647 · Cited by 13
Osborne, B. F., Beamish, S. B., & Schwarz, J. M. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.06.004 · Cited by 12
Wang, Q., Zhong, Y., Chen, N., & Chen, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1078984 · Cited by 12
“, 2012), which is evidenced by the fact that activation of microglia has been found in both MDD and anxiety disorders (Frick et al., 2013).”
Background
Metadata
- Authors
- Frick, L. R., Williams, K., & Pittenger, C.
- Affiliations
- Yale University (US)
- Corresponding author
- Pittenger, Christopher
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-10
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3652125
- OpenAlex
- W2157400052
- Cited by
- 299
- References
- 115
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 15 · 2023: 24 · 2022: 25 · 2021: 31 · 2020: 23 · 2019: 21 · 2018: 27 · 2017: 27 · 2016: 27 · 2015: 22 · 2014: 19 · 2013: 8
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Mental Health (R25MH077823)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- microglia, neuropsychiatric disorders, major depressive disorder, schizophrenia, autism spectrum disorder, obsessive-compulsive disorder, Tourette syndrome, synaptic pruning, adult neurogenesis, neuroinflammation, therapeutic target
- MeSH terms
- Animals, Autistic Disorder, Autopsy, Brain, Major Depressive Disorder, Tourette Syndrome, Humans, Inflammation, Obsessive-Compulsive Disorder, Schizophrenia, Microglia, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
